Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...
A recent study introduces an innovative method for analyzing body composition using advanced 3D imaging and deep learning techniques. This approach aims to provide more accurate assessments of ...